People News

Share this article:

Avila Therapeutics, a biopharma focused on viral infection, cancer and autoimmune diseases, appointed Katrine Bosley to CEO. Bosley was previously VP, strategic operations at Adnexus, acquired by Bristol-Myers Squibb in 2007. Prior to Adnexus, Bosley worked in various capacities – including business development, commercial operations and portfolio strategy – at Biogen Idec.

 

New York City-based Keryx Biopharmaceuticals announced the appointment of Ron Bentsur to CEO. Bensur was most recently CEO at XTL Biopharmaceuticals.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media